Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma. [electronic resource]
Producer: 20160726Description: 587-94 p. digitalISSN:- 1476-5594
- Antigens, Neoplasm -- genetics
- Carcinoma, Renal Cell -- genetics
- Cell Hypoxia -- genetics
- Cell Line, Tumor
- Cell Proliferation -- genetics
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit -- genetics
- Kidney Neoplasms -- genetics
- Ribonucleoproteins, Small Nuclear -- genetics
- Von Hippel-Lindau Tumor Suppressor Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.